TSX:WELLHealthcare
Did WELLTRUST’s AI-Powered Clinical Trial Platform Just Shift WELL Health Technologies' (TSX:WELL) Investment Narrative?
Earlier in February 2026, WELL Health and HEALWELL AI launched the first phase of WELLTRUST™, a secure, consent-based platform that uses AI to match patients in WELL-operated Canadian clinics with clinical research opportunities while maintaining privacy and regulatory compliance.
This move effectively turns WELL’s growing national clinic network and patient base into an organized research-ready cohort, potentially making the company a more important partner for pharmaceutical sponsors and...